Home/Filings/4/0001235802-15-000035
4//SEC Filing

UROPLASTY INC 4

Accession 0001235802-15-000035

CIK 0000890846operating

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 4:03 PM ET

Size

11.0 KB

Accession

0001235802-15-000035

Insider Transaction Report

Form 4
Period: 2015-03-31
Hammers Darin
Sr VP Global Sales & Marketing
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2015-03-31100,0000 total
    Exercise: $2.69Exp: 2020-02-10Common Stock (100,000 underlying)
  • Disposition to Issuer

    Common Stock

    2015-03-31131,8000 total
Footnotes (2)
  • [F1]Consists of 33,333 shares subject to restricted stock assumed by Cogentix Medical, Inc., formerly Vision-Sciences, Inc. ("Cogentix") in the merger agreement between issuer and Cogentix and replaced with 24,219 shares of Cogentix stock valued at $4.09 per share, 75,000 shares subject to restricted stock assumed by Cogentix and replaced with 54,495 shares of Cogentix stock valued at $4.56 per share and 23,467 shares disposed of pursuant to the merger agreement in exchange for 17,052 shares of Cogentix common stock on the effective date of the merger.
  • [F2]This option, which provided for vesting in three almost equal annual installments beginning on February 11, 2014, was assumed by Cogentix in the merger and replaced with an option to purchase 72,661 shares of Cogentix stock for $3.71 per share.

Issuer

UROPLASTY INC

CIK 0000890846

Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0000890846

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:03 PM ET
Size
11.0 KB